Is the current standard of care leading to cost-effective outcomes for patients with type 2 diabetes requiring insulin? A long-term health economic analysis for the UK

Jul-15

Endocrinology Healthcare Cost Pharmacoepidemiology

AUTHORS : Dr. William Valentine, Ossian Health Economics and Communications, Bäumleingasse 20, 4051 Basel, Switzerland – Email: valentine@ossianconsulting.com

JOURNAL : Diabetes Research and Clinical Practice

REFERENCE: 109(1):95-103

DOI : 10.1016/j.diabres.2015.04.023

Is the current standard of care leading to cost-effective outcomes for patients with type 2 diabetes requiring insulin? A long-term health economic analysis for the UK

More publications

Characteristics, risk factors and clinical impact of penicillin and other antibiotic allergies in adults in the UK General Practice: a population-based cohort study

Glucose Lowering through Weight management (GLoW): a randomised controlled trial of the clinical and cost effectiveness of a diabetes education and behavioural weight management programme vs a diabetes education programme in adults with a recent diagnosis of type 2 diabetes

Target Serum Urate Achievement and Chronic Kidney Disease Progression in Patients With Gout and Kidney Disease